BOSTON — Based on patient responses, quality of life with idiopathic pulmonary fibrosis was worse among those treated in community pulmonary practices vs. interstitial lung disease centers, according to data at the CHEST Annual Meeting.“We do not know how IPF care differs between ILD centers and community practices to understand why people receiving care in community practices would
The novel benzoxazole antibiotic is being developed for treating non-tuberculous mycobacteria (NTM) infections.
Inogen Inc has received FDA 510(k) clearance for the Simeox 200 airway clearance device, designed to enhance bronchial drainage.
Alpha-1 antitrypsin deficiency (AATD) is an underrecognized condition with only a small minority of affected individuals diagnosed, long delays between initial symptoms and diagnosis, and…
Impaired airway epithelial barrier and decreased expression of E-cadherin are key features of severe asthma. As a gatekeeper of the mucosa, E-cadherin can be cleaved…
Background: On the basis of recent clinical trial data for the treatment of drug-susceptible and drug-resistant tuberculosis (TB), the American Thoracic Society, U.S. Centers for…
Potential health policy administrative actions under the incoming Trump administration based on campaign positions and statements by President-elect Trump, President Trump’s record during his first…
Truth Initiative has launched the Outsmart Nicotine campaign, offering resources to support young adults in their quit resolutions for 2025.
Airway epithelial cells serve critical protective roles as biochemical and physical barriers between the lung and the external environment (1). Environmental factors, such as those…
2025 is here, but before we turn the page on the new year, RT is taking a look back at our top articles published in…
